GMAB
Genmab AS
38.50$
+10.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.1% | +3.9% | +5.3% | +2.7% | +15.5% | -86.8% | +7.2% | +8.6% | +82.9% | -3.6% | +1.1% | |
| – | +0.3% | +3.7% | -36.2% | +8.0% | +17.5% | -86.9% | +7.2% | +14.4% | -35.6% | -10.6% | +8.9% | |
| – | +4.2% | -1.3% | -70.5% | +46.4% | +55.4% | -87.7% | +7.2% | +35.9% | -2.8% | -11.1% | -1.2% | |
| – | +2.2% | +5.2% | -46.8% | +10.1% | +21.8% | -87.2% | +7.2% | +17.7% | -49.8% | -11.1% | -1.2% | |
| – | -8.9% | -5.4% | +31.8% | +2.3% | +6.0% | -86.1% | +7.2% | +4.8% | +9.9% | -10.3% | +24.2% | |
| – | -18.6% | +86.0% | -66.0% | +97.2% | -12.7% | -80.4% | +7.2% | +7.7% | +28.3% | +16.9% | -14.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +0.0% | -4.4% | +5.3% | -86.9% | +7.2% | +0.0% | -0.2% | +0.2% | +0.0% | |
| – | -12.2% | -77.2% | +52,121.7% | -4.2% | +7.3% | -86.8% | +7.2% | -0.2% | +420.7% | -1.7% | -0.8% | |
| – | -10.8% | +13.7% | +82.9% | +1.2% | +17.8% | -88.1% | +7.2% | +9.3% | +452.0% | -4.5% | -2.0% | |
| – | -14.4% | +11.1% | +58.2% | +5.1% | +15.8% | -88.9% | +7.2% | +17.8% | +92.1% | -17.3% | -3.2% | |
| – | +8.4% | +2.2% | +2.2% | -3.2% | +1.1% | -83.8% | +7.2% | +0.0% | +1,718.8% | +6.9% | +0.3% | |
| – | -1.5% | +47.4% | – | – | – | – | – | – | – | -19.3% | – | |
| – | – | +35.0% | +0.8% | -3.1% | +4.6% | – | – | – | – | -1.4% | -1.9% | |
| – | +1.6% | +2.8% | -4.7% | +3.1% | +15.0% | -86.5% | +7.2% | +8.5% | +1.4% | -2.6% | +4.8% | |
| – | +3.1% | +4.1% | -8.4% | +8.2% | +20.0% | -85.8% | +7.2% | +12.1% | +1.4% | +0.0% | +8.1% | |
| – | -0.1% | -0.2% | -1.2% | +0.0% | -1.1% | -0.3% | -3.0% | +0.1% | +8.4% | -5.1% | -3.4% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.